Kymera Therapeutics raises target price to $150 from $135
KYMR•Citigroup raised its target price for Kymera Therapeutics to $150 from $135.
Related News
Tenaris: BofA Global Research raises price objective to EUR 30 from EUR 28
TS•
Sandvik schedules Q3 2026 results webcast and investor call
SAND•
Eagle Materials: Wells Fargo cuts target price to $188 from $196
EXP•
Replenishing crude and fuel stocks could take two years, Saudi Aramco CEO says
USO•
DTE Energy Company: BMO raises target price to $134 from $132
DTE•